COMPASS THERAPEUTICS, INC. Depreciation and Amortization
COMPASS THERAPEUTICS, INC. (CMPX) reported Depreciation and Amortization of $600.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2022-03-18
- COMPASS THERAPEUTICS, INC. depreciation, depletion and amortization for the quarter ending 2021-03-31 was $200.00K, a 60.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. depreciation, depletion and amortization for the quarter ending 2020-12-31 was $1.10M, a 120.00% increase year-over-year.
- COMPASS THERAPEUTICS, INC. depreciation, depletion and amortization for the quarter ending 2020-09-30 was $400.00K, a 20.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. depreciation, depletion and amortization for the quarter ending 2020-06-30 was $400.00K, a 20.00% decline year-over-year.
- COMPASS THERAPEUTICS, INC. depreciation, depletion and amortization for fiscal 2021 was $600.00K, a 75.00% decline from fiscal 2020.
- COMPASS THERAPEUTICS, INC. depreciation, depletion and amortization for fiscal 2020 was $2.40M, a 14.29% increase from fiscal 2019.
- COMPASS THERAPEUTICS, INC. depreciation, depletion and amortization for fiscal 2019 was $2.10M.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2021-12-31 | $600.00K 10-K · filed 2022-03-18 | |||
| 2021-03-31 | $200.00K 10-Q · filed 2021-04-30 | $1.30M derived: sum of 2 quarters · filed 2022-03-18 | $1.70M derived: sum of 3 quarters · filed 2022-03-18 | $2.10M derived: sum of 4 quarters · filed 2022-03-18 |
| 2020-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $1.50M derived: sum of 2 quarters · filed 2022-03-18 | $1.90M derived: sum of 3 quarters · filed 2022-03-18 | $2.40M 10-K · filed 2022-03-18 |
| 2020-09-30 | $400.00K 10-Q · filed 2020-11-09 | $800.00K derived: sum of 2 quarters · filed 2020-11-09 | $1.30M 10-Q · filed 2020-11-09 | $1.80M derived: sum of 4 quarters · filed 2021-04-30 |
| 2020-06-30 | $400.00K 10-Q · filed 2020-08-13 | $900.00K 10-Q · filed 2020-08-13 | $1.40M derived: sum of 3 quarters · filed 2021-04-30 | $1.90M derived: sum of 4 quarters · filed 2021-04-30 |
| 2020-03-31 | $500.00K 10-Q · filed 2021-04-30 | $1.00M derived: sum of 2 quarters · filed 2021-04-30 | $1.50M derived: sum of 3 quarters · filed 2021-04-30 | $2.00M derived: sum of 4 quarters · filed 2021-04-30 |
| 2019-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $1.00M derived: sum of 2 quarters · filed 2021-03-05 | $1.50M derived: sum of 3 quarters · filed 2021-03-05 | $2.10M 10-K · filed 2021-03-05 |
| 2019-09-30 | $500.00K 10-Q · filed 2020-11-09 | $1.00M derived: sum of 2 quarters · filed 2020-11-09 | $1.60M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $500.00K 10-Q · filed 2020-08-13 | $1.10M 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |